Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: Decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11-Reference-Cited by-同舟云学术

Effects of E. Coli lipopolysaccharide on the pharmacokinetics of ipriflavone and its metabolites, M1 and M5, after intravenous and oral administration of ipriflavone to rats: Decreased metabolism of ipriflavone due to decreased expression of hepatic CYP1A2 and 2C11

Published:2008-11 Issue:11 Volume:97 Page:5024-5036
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Chung Hye J.,Kang Hee E.,Bae Eun J.,Lee Inchul,Kim Sang G.,Lee Myung G.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. Vitamin D. Chemical biochemical and clinical endocrinology of calcium metabolism;Takenaka,1982

2. Effect of ipriflavone and estrogen on the differentiation and proliferation of osteogenic cells;Kakai;Calcif Tissue Int,1992

3. Ipriflavone: Pharmacological properties and usefulness in postmenopausal osteoporosis;Reginster;Bone Miner,1993

4. Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada;Brown;Can Med Assoc J,2002

5. Metabolism of ipriflavone;Levai;Acta Pharm Hung,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimutagenic activity of ipriflavone against the DNA-damage induced by cyclophosphamide in mice;Food and Chemical Toxicology;2014-03

2. Increased Systemic Exposure to Rhizoma Coptidis Alkaloids in Lipopolysaccharide-Pretreated Rats Attributable to Enhanced Intestinal Absorption;Drug Metabolism and Disposition;2011-11-15

3. Determination of ipriflavone in human plasma by LC-MS and its application in a pharmacokinetic study;Biomedical Chromatography;2011-05-19

4. Ipriflavone pharmacokinetics in mutant Nagase analbuminemic rats;Biopharmaceutics & Drug Disposition;2009-09

5. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism;J PHARM PHARMACOL;2009